Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 2 sales; 132 institutions reported holding it in 13F filings for Q3 2026, worth $991.9M in total; no superinvestor holds it.
Holders of 5% or more of ANRO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alto Neuroscience, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 13G/A | 9.99%4.18M shares | 0.00 ppfrom 9.99% | Oct 10, 20253 filings | Aug 14, 2026 | SEC |
| Commodore Capital LP | 13G/A | 9.90%3.59M shares | 0.00 ppfrom 9.90% | Oct 27, 20253 filings | May 15, 2026 | SEC |
| Sirenia Capital Management LP | 13G/A | 6.20%2.22M shares | −1.70 ppfrom 7.90% | May 15, 20262 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 6.00%2.10M shares | +3.90 ppfrom 2.10% | Oct 21, 20244 filings | Jul 27, 2026 | SEC |
| Armistice Capital, LLC | 13G/A | 6.00%1.62M shares | 0.00 ppfrom 6.00% | Aug 14, 20252 filings | Feb 17, 2026 | SEC |
| EcoR1 Capital, LLC | 13G | 5.80%2.23M shares | New | Jul 20, 20261 filing | Jul 20, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.02%1.97M shares | New | Oct 30, 20261 filing | Oct 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
35 Schedule 13D and 13G filings on Alto Neuroscience, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 202611:01 AM ET | Vanguard Capital Management LLC | 13G | 5.02%1.97M shares | New | Sep 30, 2026 | SEC |
| Aug 14, 20265:18 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 9.99%4.18M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| Aug 14, 20264:06 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 2.20%785.0K shares | −4.30 ppfrom 6.50%Below 5% | Jun 30, 2026 | SEC |
| Aug 14, 20268:30 AM ET | Sirenia Capital Management LPand 1 other | 13G/A | 6.20%2.22M shares | −1.70 ppfrom 7.90% | Jun 30, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G | 6.00%2.10M shares | +3.90 ppfrom 2.10% | Jun 30, 2026 | SEC |
| Jul 20, 20265:10 PM ET | EcoR1 Capital, LLCand 2 others | 13G | 5.80%2.23M shares | New | Jul 13, 2026 | SEC |
| May 15, 20265:05 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 6.50%2.06M shares | −1.50 ppfrom 8.00% | Mar 31, 2026 | SEC |
| May 15, 20264:11 PM ET | Point72 Asset Management, L.P.and 5 others | 13G/A | 3.70%1.17M shares | −5.20 ppfrom 8.90%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20264:07 PM ET | Commodore Capital LPand 3 others | 13G/A | 9.90%3.59M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 15, 20268:07 AM ET | Sirenia Capital Management LPand 1 other | 13G | 7.90%2.59M shares | New | Mar 31, 2026 | SEC |
| Feb 18, 20264:46 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.94%1.54M shares | −0.97 ppfrom 5.91%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20269:53 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 6.00%1.62M shares | 0.00 ppfrom 6.00% | Dec 31, 2025 | SEC |
| Feb 17, 20264:40 PM ET | K2 HealthVentures Equity Trust LLCand 2 others | 13G/A | 2.40%789.0K shares | −3.20 ppfrom 5.60%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:30 PM ET | Point72 Asset Management, L.P.and 5 others | 13G/A | 8.90%2.82M shares | +1.90 ppfrom 7.00% | Dec 31, 2025 | SEC |
| Feb 17, 20264:13 PM ET | Commodore Capital LPand 3 others | 13G/A | 9.90%3.25M shares | +0.10 ppfrom 9.80% | Dec 31, 2025 | SEC |
| Feb 17, 20264:05 PM ET | Vestal Point Capital, LPand 1 other | 13G | 8.00%2.48M shares | New | Dec 31, 2025 | SEC |
| Feb 17, 20264:00 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 9.99%3.25M shares | +2.69 ppfrom 7.30% | Dec 31, 2025 | SEC |
| Oct 27, 20254:02 PM ET | Commodore Capital LPand 3 others | 13G | 9.80%3.19M shares | New | Oct 20, 2025 | SEC |
| Oct 10, 202512:50 PM ET | Perceptive Advisors LLCand 2 others | 13G | 7.30%1.99M shares | New | Oct 3, 2025 | SEC |
| Aug 14, 20259:36 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 6.00%1.62M shares | – | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 2.10%561.4K shares | –Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:26 PM ET | Point72 Asset Management, L.P.and 5 others | 13G/A | 7.00%1.91M shares | −1.80 ppfrom 8.80% | Mar 31, 2025 | SEC |
| May 15, 20253:19 PM ET | K2 HealthVentures Equity Trust LLCand 2 others | 13G | 5.60%1.62M shares | New | Jan 13, 2025 | SEC |
| May 15, 20253:05 PM ET | Armistice Capital, LLCand 1 other | 13G | 5.91%1.60M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20256:26 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:05 PM ET | Point72 Asset Management, L.P.and 5 others | 13G/A | 8.80%2.36M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:16 AM ET | FMR LLCand 1 other | 13G/A | 4.70%1.27M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Etkin Amit | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Mar 29, 2024 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | Falcon Edge Capital, LP | 13GOld format | – | New | – | SEC |
| Feb 7, 2024 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Alto Neuroscience, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20264:45 PM ET | Michael HanleyOfficer | 75.0K | $2.22M | Nov 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 29, 20264:23 PM ET | Nicholas SmithOfficer | 134.9K | $3.60M | Sep 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |